Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate

被引:24
作者
Kielstein, Jan T. [1 ,4 ]
Salpeter, Shelley R. [2 ]
Buckley, Nicholas S. [3 ]
Cooke, John P. [1 ]
Fliser, Danilo [4 ]
机构
[1] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] CALTECH, Pasadena, CA 91125 USA
[4] Hannover Med Sch, Div Nephrol, Dept Internal Med, D-3000 Hannover, Germany
关键词
kidney; meta-analysis; risk factors; Cockcroft-Gault equation; modification of diet in renal disease formula; glomerular filtration rate; homocysteine;
D O I
10.1159/000142725
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Hyperhomocysteinemia is thought to be an independent risk factor for cardiovascular disease, but the association between renal dysfunction and homocysteine may not have been fully taken into account. We performed a meta-analysis of studies that report correlations between glomerular filtration rate (GFR) and homocysteine plasma levels. Methods: Using a prespecified research strategy, we identified 41 studies involving 26,617 participants that reported Pearson or Spearman correlation coefficients for the association between 1/GFR and homocysteine. The summary correlation coefficients with 95% CI were obtained by pooling the logarithmic Z values derived from the individual trial correlation coefficients. Subgroup analysis was performed to compare results for measured GFR using clearance methods and various estimates of GFR. Results: The pooled correlation coefficient between homocysteine and 1/GFR was 0.37 (CI 0.32-0.40, p < 0.0001). The correlation coefficient based on various estimates of GFR was 0.33 (CI 0.29 - 0.38, p < 0.0001), and for measured GFR it was 0.45 (CI 0.39 - 0.51, p < 0.0001). The correlation coefficient was higher when GFR was measured using clearance methods compared with various estimates GFR (1.36 [CI 1.13-1.65], p = 0.0014). Conclusions: Homocysteine plasma levels significantly depend on renal function. This correlation is even more robust when GFR is measured using clearance methods. Therefore, in order to assess whether homocysteine is an independent cardiovascular risk factor, accurate adjustments for renal dysfunction are essential. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 81 条
  • [11] Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine
    Bostom, AG
    Bausserman, L
    Jacques, PF
    Liaugaudas, G
    Selhub, J
    Rosenberg, IH
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (09) : 2241 - 2244
  • [12] Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine:: critical impact of true glomerular filtration rate
    Bostom, AG
    Kronenberg, F
    Jacques, PF
    Kuen, E
    Ritz, E
    König, P
    Kraatz, G
    Lhotta, K
    Mann, JFE
    Müller, GA
    Neyer, U
    Riegel, W
    Schwenger, V
    Riegler, P
    Selhub, J
    [J]. ATHEROSCLEROSIS, 2001, 159 (01) : 219 - 223
  • [13] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [14] Brattström L, 2000, AM J CLIN NUTR, V72, P315
  • [15] Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease - A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the councils on high blood pressure research, cardiovascular disease in the young, and epidemiology and prevention; and the quality of care and outcomes research interdisciplinary working group
    Brosius, Frank C., III
    Hostetter, Thomas H.
    Kelepouris, Ellie
    Mitsnefes, Mark M.
    Moe, Sharon M.
    Moore, Michael A.
    Pennathur, Subramaniam
    Smith, Grace L.
    Wilson, Peter W. F.
    [J]. CIRCULATION, 2006, 114 (10) : 1083 - 1087
  • [16] Homocysteine, folate, vitamin B12 levels, and C677T MTHFR mutation in children with renal failure
    Canepa, A
    Carrea, A
    Caridi, G
    Dertenois, L
    Minniti, G
    Cerone, R
    Canini, S
    Calevo, MG
    Perfumo, F
    [J]. PEDIATRIC NEPHROLOGY, 2003, 18 (03) : 225 - 229
  • [17] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
    Clarke, R
    Collins, R
    Lewington, S
    Donald, A
    Alfthan, G
    Tuomilehto, J
    Arnesen, E
    Bonaa, K
    Blacher, J
    Boers, GHJ
    Bostom, A
    Bots, ML
    Grobee, DE
    Brattström, L
    Breteler, MMB
    Hofman, A
    Chambers, JC
    Kooner, JS
    Coull, BM
    Evans, RW
    Kuller, LH
    Evers, S
    Folsom, AR
    Freyburger, G
    Parrot, F
    Genst, J
    Dalery, K
    Graham, IM
    Daly, L
    Hoogeveen, EK
    Kostense, PJ
    Stehouwer, CDA
    Hopknis, PN
    Jacques, P
    Selhub, J
    Luft, FC
    Jungers, P
    Lindgren, A
    Lolin, YI
    Loehrer, F
    Fowler, B
    Mansoor, MA
    Malinow, MR
    Ducimetiere, P
    Nygard, O
    Refsum, H
    Vollset, SE
    Ueland, PM
    Omenn, GS
    Beresford, SAA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16): : 2015 - 2022
  • [18] Plasma homocysteine levels and C677T MTHFR gene polymorphism in stable renal graft recipients
    Cossu, M
    Carru, C
    Pes, GM
    Satta, R
    Mura, A
    Errigo, A
    Sanna, S
    Naitana, A
    Deiana, L
    Sorba, G
    Pinna, GG
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1156 - 1158
  • [19] Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients
    Darius, H
    Pittrow, D
    Haberl, R
    Trampisch, HJ
    Schuster, A
    Lange, S
    Tepohl, HG
    Allenberg, JR
    Diehm, C
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (09) : 751 - 757
  • [20] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188